NCT04444557 (COST-HD) is a clinical trial of Beck Depression Inventory (BDI) in Depression, sponsored by Sisli Hamidiye Etfal Training and Research Hospital.

Who is sponsoring NCT04444557?

NCT04444557 is sponsored by Sisli Hamidiye Etfal Training and Research Hospital.

What drugs are being tested in NCT04444557?

Interventions in NCT04444557: Beck Depression Inventory (BDI).

What condition does NCT04444557 study?

NCT04444557 studies Depression, Hemodialysis.

Is NCT04444557 still recruiting?

NCT04444557 is currently completed. Last updated 23 June 2020.

Last reviewed 2020-06-23 · How we verify

NCT04444557: COST-HD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of COvid-19 on Mental Health in Syrian and Turkish Maintenance HemoDialysis Patients: COST-HD Study

Completed Last updated 23 June 2020

What this trial tests

trial testing Beck Depression Inventory (BDI) in Depression in 97 participants. Completed in 1 May 2020.

Timeline

17 April 2020

Primary endpoint
1 May 2020

1 May 2020

Quick facts

Lead sponsor	Sisli Hamidiye Etfal Training and Research Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	97
Start date	17 April 2020
Primary completion	1 May 2020
Estimated completion	1 May 2020
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Beck Depression Inventory (BDI)

Conditions studied

Depression — all drugs for Depression →
Hemodialysis — all drugs for Hemodialysis →

Sponsor

Sisli Hamidiye Etfal Training and Research Hospital

Who can join

18 and older, any sex, with Depression or Hemodialysis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

SARS-COV infection first has begun at Wuhan, China, and then became a pandemic. The first COVID-19 case has been reported on March 11, 2020, in Turkey. People older than 65 years old have been locked down on March 21 and people younger than 20 years old locked down at April 03. A total lockdown has been done a few times lasting for 3 or 4 days, especially at weekends. Renal replacement modalities have been affected in different ways during the pandemic. Patients with kidney transplantation and patients performing home hemodialysis or peritoneal dialysis have been advised to perform self-isolation at homes. However, center hemodialysis patients continued to come dialysis centers obligatorily. Syrian civil war has been continuing since 2011, and Turkey has accepted millions of Syrian people in a position called temporary protection. There are many Syrian center hemodialysis patients both in Turkey and in our unit. The investigators do not know if pandemic affected Syrian patients different than Turkish ones. The aim of this study is to compare beck depression scores of Turkish and Syrian patients undergoing hemodialysis during the COVID-19 pandemic.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Frequency of depressive symptoms in Syrian refugees and Turkish maintenance hemodialysis patients during COVID-19 pandemic.
Sevinc M, Hasbal NB, Sakaci T, Basturk T, et al · · 2021 · cited 9× · PMID 33395428 · DOI 10.1371/journal.pone.0244347

Verify or expand the search:

Other trials of Beck Depression Inventory (BDI)

Trials testing the same drug.

NCT05950698 — Obesity and Bariatric Surgery According to a Biopsychosocial Perspective. · recruiting
NCT05167565 — Longitudinal Development of Behavior and Its Underlying Neural Correlates in Human Infants · NA · completed
NCT03364803 — Collecting Information About Treatment Results for Patients With Cushing's Syndrome · recruiting

Other recruiting trials for Depression

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting

Other Sisli Hamidiye Etfal Training and Research Hospital trials

Trials by the same sponsor.

NCT07334002 — The Effects of Conventional Therapy on Tinnitus, Disability, and Quality of Life in Patients With Tinnitus · NA · not yet recruiting
NCT07321041 — Effect of Delivery Time on Umbilical Cord Blood Gas Parameters in Cesarean Sections Under General and Spinal Anesthesia · recruiting
NCT07476690 — Effect of rESWT Session Frequency on Spasticity and Function Assessed by Sonoelastography in Children With Cerebral Pals · NA · recruiting
NCT07166614 — Dexmedetomidine vs Propofol in High-Risk ERCP Patients · NA · recruiting
NCT07250243 — Turkish Validation and Reliability of the John Hopkins In-Room Independence Scale · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04444557 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sisli Hamidiye Etfal Training and Research Hospital
Last refreshed: 23 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04444557.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing